Animal models in retinoblastoma research

Saudi Journal of Ophthalmology

Volumn 27, Issue 3, 2013, Pages 141-146

  Nair, Rohini M ^a   Kaliki, Swathi ^b   Vemuganti, Geeta K ^a  

^a UNIVERSITY OF HYDERABAD   (India)

^b L V PRASAD EYE INSTITUTE   (India)

Author keywords

Knock out genetic model; Preclinical models; Retinoblastoma; Xenograft models

Indexed keywords

CARBOPLATIN; CHX10 PROTEIN; ETOPOSIDE; NESTIN; PROTEIN P130; PROTEIN P53; RETINOBLASTOMA PROTEIN; TOPOTECAN; TRANSCRIPTION FACTOR PAX6; UNCLASSIFIED DRUG; VINCRISTINE;

APOPTOSIS; ARTICLE; BIOLUMINESCENCE; CANCER LOCALIZATION; CANCER RESEARCH; CELL PROLIFERATION; CRYOTHERAPY; ELECTRON MICROSCOPY; ENUCLEATION; EXTERNAL BEAM RADIOTHERAPY; FLUORESCENCE IMAGING; GENE INACTIVATION; GENE LOSS; GENE MUTATION; GENETIC MODEL; GENETIC RISK; GERM LINE; HISTOLOGY; HUMAN; IMAGING; METASTASIS; MICRO-COMPUTED TOMOGRAPHY; MOLECULAR BIOLOGY; MUTATION; NERVE CELL DIFFERENTIATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PHENOTYPIC VARIATION; PHOTODYNAMIC THERAPY; PHOTORECEPTOR; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RETINA DEVELOPMENT; RETINOBLASTOMA; TRANSGENIC ANIMAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT;

EID: 84883449635     PISSN: 13194534     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sjopt.2013.06.008     Document Type: Article

References (59)

1. Corpet D.E., Pierre F. Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol Biomarkers Prev 2003, 12(5):391-400.
2. Walker G.J., et al. Modelling melanoma in mice. Pigment Cell Melanoma Res 2011, 24(6):1158-1176.
3. Kim J.B., O'Hare M.J., Stein R. Models of breast cancer: is merging human and animal models the future?. Breast Cancer Res 2004, 6(1):22-30.
4. Mullany L.K., Richards J.S. Minireview: animal models and mechanisms of ovarian cancer development. Endocrinology 2012, 153(4):1585-1592.
5. Li Y., Tang Z.Y., Hou J.X. Hepatocellular carcinoma: insight from animal models. Nat Rev Gastroenterol Hepatol 2012, 9(1):32-43.
6. Blanco P.L., Caissie A.L., Burnier M.N. Experimental models of uveal melanoma. Can J Ophthalmol 2004, 39(4):441-447.
7. Deegan W.F. Emerging strategies for the treatment of retinoblastoma. Curr Opin Ophthalmol 2003, 14(5):291-295.
8. DiCiommo D., Gallie B.L., Bremner R. Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer. Semin Cancer Biol 2000, 10(4):255-269.
9. Sachdeva U.M., O'Brien J.M. Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma. J Clin Invest 2012, 122(2):425-434.
10. Dimaras H., et al. Retinoblastoma. Lancet 2012, 379(9824):1436-1446.
11. Xu K., et al. Preimplantation genetic diagnosis for retinoblastoma: the first reported liveborn. Am J Ophthalmol 2004, 137(1):18-23.
12. Richter S., et al. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet 2003, 72(2):253-269.
13. Houston S.K., et al. Current update on retinoblastoma. Int Ophthalmol Clin 2011, 51(1):77-91.
14. Demirci H., et al. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction. Arch Ophthalmol 2003, 121(8):1125-1131.
15. Knudson A.G. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971, 68(4):820-823.
16. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674.
17. Dimaras H., et al. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet 2008, 17(10):1363-1372.
18. Bowles E., et al. Profiling genomic copy number changes in retinoblastoma beyond loss of RB1. Genes Chromosomes Cancer 2007, 46(2):118-129.
19. Marchong M.N., et al. Cdh11 acts as a tumor suppressor in a murine retinoblastoma model by facilitating tumor cell death. PLoS Genet 2010, 6(4):e1000923.
20. Garraway L.A., Lander E.S. Lessons from the cancer genome. Cell 2013, 153(1):17-37.
21. Macpherson D. Insights from mouse models into human retinoblastoma. Cell Div 2008, 3:9.
22. Dyer M.A., Rodriguez-Galindo C., Wilson M.W. Use of preclinical models to improve treatment of retinoblastoma. PLoS Med 2005, 2(10):e332.
23. Robanus-Maandag E., et al. P107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev 1998, 12(11):1599-1609.
24. Windle J.J., et al. Retinoblastoma in transgenic mice. Nature 1990, 343(6259):665-669.
25. Hahn W.C., et al. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 2002, 22(7):2111-2123.
26. Marcus D.M., et al. Trilateral tumors in four different lines of transgenic mice expressing SV40 T-antigen. Invest Ophthalmol Vis Sci 1996, 37(2):392-396.
27. al-Ubaidi M.R., et al. Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter. J Cell Biol 1992, 119(6):1681-1687.
28. Pajovic S., et al. The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties. Invest Ophthalmol Vis Sci 2011, 52(10):7618-7624.
29. Wadhwa L., et al. Embryonic retinal tumors in SV40 T-Ag transgenic mice contain CD133+ tumor-initiating cells. Invest Ophthalmol Vis Sci 2012, 53(7):3454-3462.
30. Murray T.G., et al. Local carboplatin and radiation therapy in the treatment of murine transgenic retinoblastoma. Arch Ophthalmol 1996, 114(11):1385-1389.
31. Murray T.G., et al. Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma. Arch Ophthalmol 1997, 115(10):1286-1290.
32. Jockovich M.E., et al. Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model. Invest Ophthalmol Vis Sci 2007, 48(12):5371-5376.
33. Ruggeri M., et al. In vivo three-dimensional high-resolution imaging of rodent retina with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2007, 48(4):1808-1814.
34. Dimaras H., Marchong M.N., Gallie B.L. Quantitative analysis of tumor size in a murine model of retinoblastoma. Ophthalmic Genet 2009, 30(2):84-90.
35. Williams B.O., et al. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J 1994, 13(18):4251-4259.
36. Maandag E.C., et al. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J 1994, 13(18):4260-4268.
37. Zhu L., et al. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev 1993, 7(7A):1111-1125.
38. MacPherson D., et al. Cell type-specific effects of Rb deletion in the murine retina. Genes Dev 2004, 18(14):1681-1694.
39. Donovan S.L., et al. Compensation by tumor suppressor genes during retinal development in mice and humans. BMC Biol 2006, 4:14.
40. Vooijs M., et al. Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells. Oncogene 2002, 21(30):4635-4645.
41. Zhang J., Schweers B., Dyer M.A. The first knockout mouse model of retinoblastoma. Cell Cycle 2004, 3(7):952-959.
42. Chen D., et al. Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 2004, 5(6):539-551.
43. MacPherson D., et al. Murine bilateral retinoblastoma exhibiting rapid-onset, metastatic progression and N-myc gene amplification. EMBO J 2007, 26(3):784-794.
44. Saavedra H.I., et al. Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb. Cell Growth Differ 2002, 13(5):215-225.
45. Johnson D.A., Donovan S.L., Dyer M.A. Mosaic deletion of Rb arrests rod differentiation and stimulates ectopic synaptogenesis in the mouse retina. J Comp Neurol 2006, 498(1):112-128.
46. Masland R.H. The fundamental plan of the retina. Nat Neurosci 2001, 4(9):877-886.
47. Johnson D.A., et al. Neuronal differentiation and synaptogenesis in retinoblastoma. Cancer Res 2007, 67(6):2701-2711.
48. Dannenberg J.H., et al. Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130. Genes Dev 2004, 18(23):2952-2962.
49. Ajioka I., et al. Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice. Cell 2007, 131(2):378-390.
50. McEvoy J., et al. Coexpression of normally incompatible developmental pathways in retinoblastoma genesis. Cancer Cell 2011, 20(2):260-275.
51. Laurie N.A., et al. Topotecan combination chemotherapy in two new rodent models of retinoblastoma. Clin Cancer Res 2005, 11(20):7569-7578.
52. McFall R.C., Sery T.W., Makadon M. Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res 1977, 37(4):1003-1010.
53. Kang S.J., Grossniklaus H.E. Rabbit model of retinoblastoma. J Biomed Biotechnol 2011, 2011:394730.
54. Gallie B.L., et al. Heterotransplantation of retinoblastoma into the athymic "nude" mouse. Invest Ophthalmol Vis Sci 1977, 16(3):256-259.
55. del Cerro M., et al. Transplantation of Y79 cells into rat eyes: an in vivo model of human retinoblastomas. Invest Ophthalmol Vis Sci 1993, 34(12):3336-3346.
56. Chevez-Barrios P., et al. Metastatic and nonmetastatic models of retinoblastoma. Am J Pathol 2000, 157(4):1405-1412.
57. Aerts I., et al. In vivo efficacy of photodynamic therapy in three new xenograft models of human retinoblastoma. Photodiagnosis Photodyn Ther 2010, 7(4):275-283.
58. Dalgard C.L., Van Quill K.R., O'Brien J.M. Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma. Clin Cancer Res 2008, 14(10):3113-3123.
59. Ji X., et al. Noninvasive visualization of retinoblastoma growth and metastasis via bioluminescence imaging. Invest Ophthalmol Vis Sci 2009, 50(12):5544-5551.